|
|
 |
|
|
|
Committee: Senate Committee on
Health, Education, Labor, and
Pensions |
|
Title:
Drug User Fees: Enhancing Patient
Access and Drug Safety |
|
Date:
Wednesday, March 14, 10:15 a.m. |
|
Place: Dirksen 430 |
 |
|
Audio / Video: Click
here to view hearing |
|
Hearing File: |
Click Here to download Real
Player |
 |
|
Witness
Testimony |
 |
Andrew von Eschenbach, MD,
Commissioner of Food and
Drugs, Rockville, MD
 |
|
|
Kim Witczak, Founder of
Woody Matters, Minneapolis,
MN
|
|
|
Mark McClellan, MD, PhD,
American Enterprise
Institute, Washington, DC
|
|
|
D. Bruce Burlington, MD,
Executive Vice President,
Quality, Regulatory and
Safety, Wyeth
Pharmaceuticals,
Collegeville, PA
|
|
|
Diane Dorman, Vice
President, Public Policy,
National Organization for
Rare Disorders, Washington,
DC
|
|
|
|
|
|
Click Here
to download Adobe Reader |
|
|
| |
